Financials in USD. Standardized financial statements.
A compact view of how CV Sciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $13.79M | $15.71M | $16.00M | $16.20M | $20.05M | $24.43M | $53.70M | $48.24M | $20.68M | $11.06M |
| Revenue Growth? | -12.2% | -1.9% | -1.2% | -19.2% | -17.9% | -54.5% | +11.3% | +133.3% | +87.0% | 0.0% |
| Cost of Revenue? | $7.04M | $8.54M | $8.92M | $10.65M | $11.43M | $13.42M | $18.61M | $14.37M | $6.19M | $4.06M |
| Gross Profit? | $6.75M | $7.17M | $7.08M | $5.55M | $8.62M | $11.01M | $35.09M | $33.88M | $14.49M | $7.00M |
| Gross Margin? | +49.0% | +45.6% | +44.3% | +34.2% | +43.0% | +45.1% | +65.3% | +70.2% | +70.1% | +63.3% |
| Operating Expenses? | $7.74M | $9.36M | $3.73M | $12.40M | $27.06M | $33.60M | $52.33M | $23.63M | $16.98M | $13.91M |
| Operating Income? | -$992,000 | -$2.19M | $3.36M | -$6.85M | -$18.45M | -$22.59M | -$17.24M | $10.25M | -$4.86M | -$13.07M |
| EBITDA? | -$562,000 | -$1.86M | $3.85M | -$5.66M | -$14.00M | -$21.72M | -$15.69M | $10.77M | -$4.69M | -$12.00M |
| Income Before Tax | -$949,000 | -$2.40M | $3.10M | -$8.26M | -$15.64M | -$22.60M | -$17.23M | $10.09M | -$5.38M | -$14.14M |
| Income Tax Expense | $9,000 | -$8,000 | -$6,000 | -$47,000 | -$87,000 | -$317,000 | -$615,000 | $93,000 | -$481,500 | $0 |
| Net Income? | -$958,000 | -$2.39M | $3.10M | -$8.21M | -$15.55M | -$22.28M | -$16.61M | $10.00M | -$4.90M | -$14.14M |
| EPS? | $-0.01 | $-0.01 | $0.02 | $-0.06 | $-0.14 | $-0.22 | $-0.17 | $0.09 | $-0.06 | $-0.27 |
| Diluted EPS? | $-0.01 | $-0.01 | $0.02 | $-0.06 | $-0.14 | $-0.22 | $-0.17 | $0.09 | $-0.06 | $-0.27 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality